PATENT CLAIM ANALYSIS

Application Number: 15902547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "249000"]

Abstract:
In one aspect, the invention relates to substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 1  (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 8):
The compound of  claim 1 , having a structure represented by a formula: wherein each of R 5a , R 5b , R 5c , and R 5d  is independently selected from hydrogen, halogen, hydroxyl, cyano, \u2014NH 2 , C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 polyhaloalkyl, C1-C6 alkylamino, and C1-C6 dialkylamino, provided that at least one of R 5a , R 5b , R 5c , and R 5d  is hydrogen; and wherein R 6  is selected from hydrogen and C1-C6 alkyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.56716
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14787722', '14354560', '14787717', '14913266', '13692969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8495046729689201
- 35 USC 102 Novelty (BERT): 0.6069231809607144
- Combined Prediction Score: 0.8252465237680995
- Mean Citation Score: 595.6632320000001
- Max Citation Score: 602.8802
- Similarity Product: 444.9854038149118

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test